Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

Similar articles for PubMed (Select 22914564)

1.

Radioactive iodine therapy.

Lee SL.

Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):420-8. doi: 10.1097/MED.0b013e328357fa0c. Review.

PMID:
22914564
2.

Appropriate dosing of adjuvant radioactive iodine for differentiated thyroid cancer.

Bohinc BN, Perkins JM.

Curr Opin Oncol. 2014 Jan;26(1):31-5. doi: 10.1097/CCO.0000000000000039. Review.

PMID:
24225414
3.

Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.

Tuttle RM, Lopez N, Leboeuf R, Minkowitz SM, Grewal R, Brokhin M, Omry G, Larson S.

Thyroid. 2010 Mar;20(3):257-63. doi: 10.1089/thy.2009.0401.

PMID:
20187781
4.

Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.

Patel SS, Goldfarb M.

J Surg Oncol. 2013 May;107(6):665-72. doi: 10.1002/jso.23295. Epub 2012 Nov 28. Review.

PMID:
23192391
5.
6.

Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making.

Tuttle RM, Sabra MM.

Oral Oncol. 2013 Jul;49(7):676-83. doi: 10.1016/j.oraloncology.2013.03.444. Epub 2013 Apr 16. Review.

PMID:
23601564
7.

Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.

Sawka AM, Ibrahim-Zada I, Galacgac P, Tsang RW, Brierley JD, Ezzat S, Goldstein DP.

Thyroid. 2010 Oct;20(10):1129-38. doi: 10.1089/thy.2010.0055. Review.

8.

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial.

Sawka AM, Straus S, Brierley JD, Tsang RW, Rotstein L, Rodin G, Gafni A, Ezzat S, Thabane L, Thorpe KE, Goldstein DP.

Trials. 2010 Jul 26;11:81. doi: 10.1186/1745-6215-11-81.

9.

Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.

Ghadban WK, Zirie MA, Al-Khateeb DA, Jayyousi AA, Mobayedh HM, El-Aloosy AS.

Saudi Med J. 2003 Apr;24(4):347-51.

PMID:
12754531
10.

The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.

Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ.

Cancer. 2013 Jan 15;119(2):259-65. doi: 10.1002/cncr.27721. Epub 2012 Jun 28.

11.

Evaluation of surgical completeness in endoscopic thyroidectomy compared with open thyroidectomy with regard to remnant ablation.

Im HJ, Koo do H, Paeng JC, Lee KE, Chung YS, Lim I, Lee DS, Chung JK, Youn YK.

Clin Nucl Med. 2012 Feb;37(2):148-51. doi: 10.1097/RLU.0b013e3182335fdc.

PMID:
22228337
12.

Long-term follow-up study of radioiodine treatment of hyperthyroidism.

Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J.

Clin Endocrinol (Oxf). 2004 Nov;61(5):641-8.

PMID:
15521969
13.

ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States?

Famakinwa OM, Roman SA, Wang TS, Sosa JA.

Am J Surg. 2010 Feb;199(2):189-98. doi: 10.1016/j.amjsurg.2009.04.022.

PMID:
20113699
14.

Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.

Walter MA, Christ-Crain M, Eckard B, Schindler C, Nitzsche EU, Müller-Brand J, Müller B.

Eur J Clin Invest. 2004 May;34(5):365-70.

PMID:
15147334
15.

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I.

Cancer. 2011 Oct 1;117(19):4439-46. doi: 10.1002/cncr.26070. Epub 2011 Mar 22.

16.

Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.

Laird AM, Gauger PG, Miller BS, Doherty GM.

World J Surg. 2012 Jun;36(6):1268-73. doi: 10.1007/s00268-012-1431-5.

PMID:
22270997
17.

Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer.

Sawka AM, Straus S, Rotstein L, Brierley JD, Tsang RW, Asa S, Segal P, Kelly C, Zahedi A, Freeman J, Solomon P, Anderson J, Thorpe KE, Gafni A, Rodin G, Goldstein DP.

J Clin Oncol. 2012 Aug 10;30(23):2906-11. doi: 10.1200/JCO.2011.41.2734. Epub 2012 Jul 2.

18.

Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma.

Yuan L, Yang J.

J Pediatr Endocrinol Metab. 2011;24(11-12):877-83. Review.

PMID:
22308835
19.

The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer.

Van Nostrand D, Aiken M, Atkins F, Moreau S, Garcia C, Acio E, Burman K, Wartofsky L.

Thyroid. 2009 Aug;19(8):849-55. doi: 10.1089/thy.2008.0419.

PMID:
19281428
20.

An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer.

Sawka AM, Brierley JD, Tsang RW, Thabane L, Rotstein L, Gafni A, Straus S, Goldstein DP.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):457-80, x. doi: 10.1016/j.ecl.2008.02.007. Review.

PMID:
18502337
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk